Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →30
🟠 Elevated
🤖 ML Fraud Detection Score: 95%
Machine learning model identifies prescribing patterns consistent with confirmed fraud cases. This is a statistical indicator, not an accusation.
Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
101,128
Total Claims
$7.8M
Drug Cost
1,406
Beneficiaries
$5,543
Cost/Patient
Risk Score Breakdown 30/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-62%
Opioid rate vs peers
0.9% vs 2.2% avg
+293%
Cost per patient vs peers
$5,543 vs $1,411 avg
+35%
Brand preference vs peers
14.3% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
0.9%
Opioid Rate
860
Opioid Claims
$9,585
Opioid Cost
2.3%
Long-Acting Rate
Brand vs Generic
Brand: 14,436 claims · $5.6M
Generic: 86,351 claims · $2.2M
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 2,132 | $600K |
| Empagliflozin | 1,134 | $355K |
| Aripiprazole Lauroxil | 127 | $333K |
| Valbenazine Tosylate | 52 | $282K |
| Paliperidone Palmitate | 92 | $267K |
| Sitagliptin Phosphate | 725 | $189K |
| Risperidone Microspheres | 142 | $178K |
| Linagliptin | 583 | $163K |
| Semaglutide | 140 | $139K |
| Empagliflozin/Metformin Hcl | 416 | $117K |
| Rivaroxaban | 388 | $111K |
| Fluticasone Propion/Salmeterol | 258 | $109K |
| Dulaglutide | 124 | $107K |
| Aripiprazole | 587 | $107K |
| Lurasidone Hcl | 109 | $105K |
Prescribing Profile
Patient Profile
69
Avg Age
48%
Female
2.77
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About